These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 124527)

  • 21. Effects of nicotinic acid and nicotinamide on serum cholesterol and erythrocyte nicotinamide adenine dinucleotide levels of rabbits.
    Fontenot R; Redetzki H; Deupree R
    Proc Soc Exp Biol Med; 1965; 119(4):1053-5. PubMed ID: 4284310
    [No Abstract]   [Full Text] [Related]  

  • 22. Enzymatic hydrolysis of pentaerythritoltetranicotinate and meso-inositolhexanicotinate in blood and tissues.
    Harthon L; Brattsand R
    Arzneimittelforschung; 1979; 29(12):1859-62. PubMed ID: 546424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Arteriosclerosis--nicotinic acid therapy. 12. Some effects on experimental animals].
    Brattsand R; Lindström E
    Lakartidningen; 1971 Apr; 68(15):1776-82. PubMed ID: 4325229
    [No Abstract]   [Full Text] [Related]  

  • 24. The effects of different dose regimens of niceritrol of serum lipid concentrations in man.
    Rössner S; Olsson AG; Orö L
    Acta Med Scand; 1976; 200(4):269-71. PubMed ID: 983794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and metabolic effects of pentaerythritol tetranicotinate(Perycit)and a comparison with plain nicotinic acid.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1974; 19(1):61-73. PubMed ID: 4359183
    [No Abstract]   [Full Text] [Related]  

  • 26. High-performance liquid chromatographic determination of nicotinic acid and its metabolites, nicotinuric acid and nicotinamide, in plasma.
    Takikawa K; Miyazaki K; Arita T
    J Chromatogr; 1982 Dec; 233():343-8. PubMed ID: 6219121
    [No Abstract]   [Full Text] [Related]  

  • 27. Nocturnal inhibition of lipolysis in man by nicotinic acid and derivatives.
    Kruse W; Kruse W; Raetzer H; Heuck CC; Oster P; Schellenberg B; Schlierf G
    Eur J Clin Pharmacol; 1979 Aug; 16(1):11-5. PubMed ID: 499296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between lipemia and sensitivity to arachidonic acid in rabbits].
    Deby C; Deby-Dupont G; Bourdon-Neuray J; Simon D
    C R Seances Soc Biol Fil; 1978; 172(5):1017-24. PubMed ID: 157189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of nicotinic acid on muscle lipid concentration in man.
    Fröberg SO; Castenfors H
    Acta Med Scand; 1974; 196(1-2):65-7. PubMed ID: 4418517
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased compliance of niceritrol treatment by addition of aspirin: relationship between changes in prostaglandins and skin flushing.
    Nozaki S; Kihara S; Kubo M; Kameda K; Matsuzawa Y; Tarui S
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):643-7. PubMed ID: 3481359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous determination of nicotinic acid and its two metabolites in human plasma using solid-phase extraction in combination with high performance liquid chromatography.
    Miyauchi Y; Sano N; Nakamura T
    Int J Vitam Nutr Res; 1993; 63(2):145-9. PubMed ID: 8407165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thermographic registration of flush.
    Aberg G; Svedmyr N
    Arzneimittelforschung; 1971 Jun; 21(6):795-6. PubMed ID: 5109263
    [No Abstract]   [Full Text] [Related]  

  • 33. Potential hypolipidemic agents. X. Plasma lipid-lowering properties of some aliphatic aminoalcohols.
    Bondesson G; Hedbom C; Magnusson O; Stjernström NE
    Acta Pharm Suec; 1974 Nov; 11(5):417-26. PubMed ID: 4440500
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of nicotinic acid on the posttraumatic increase in free fatty acids and fibrinolysis inhibition activity in the rat.
    Wegener T; Bagge L; Saldeen T
    Ups J Med Sci; 1979; 84(3):195-201. PubMed ID: 543049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L; Olsson AG; Rössner S; Carlson LA
    Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of nicotinic acid on the diurnal variation of the free fatty acids of plasma.
    Carlström S; Laurell S
    Acta Med Scand; 1968; 184(1-2):121-3. PubMed ID: 5317782
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum and tissue lipid metabolism and effect of nicotinic acid in different types of hyperlipidemia.
    Carlson LA; Walldius G
    Adv Exp Med Biol; 1972; 26(0):165-78. PubMed ID: 4370366
    [No Abstract]   [Full Text] [Related]  

  • 39. Experimental atherogenesis and vascular noradrenaline content in NZW rabbits and activity of a new nicotinic acid derivative (L 44-0).
    Teixeira F; Beja ML; Serra e Silva P; Cabrita S; França MB; Almeida L; Morgadinho MT
    J Lipid Mediat; 1991; 3(2):167-75. PubMed ID: 1797152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anti-platelet effect of niceritrol in patients with arteriosclerosis and the relationship of the lipid-lowering effect to the anti-platelet effect.
    Nagakawa Y; Orimo H; Harasawa M
    Thromb Res; 1985 Nov; 40(4):543-53. PubMed ID: 4082125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.